Copyright
©The Author(s) 2022.
World J Orthop. Oct 18, 2022; 13(10): 903-910
Published online Oct 18, 2022. doi: 10.5312/wjo.v13.i10.903
Published online Oct 18, 2022. doi: 10.5312/wjo.v13.i10.903
Covariate | Infection (yes) | Infection (not) | P value |
Age, mean (min-max) | 62.8 (51-69) | 62.8 (17-88) | P = 0.98; T-test |
Sex | |||
Female (%) | 3 (75.0) | 317 (54.7) | P = 0.63; Fisher’s test |
Male (%) | 1 (25.0) | 262 (45.3) | |
BMI | |||
Underweight (%) | - | 4 (0.7) | P = 0.455; χ2 test |
Normal (%) | 1 (25.0) | 208 (36.0) | |
Overweight (%) | 1 (25.0) | 259 (44.8) | |
Obese (%) | 2 (50.0) | 107 (18.5) | |
Antibiotic therapy | |||
Cefazolin (%) | 4 (100.0) | 560 (96.9) | P = 1.00; Fisher’s test |
Clindamycin (%) | - | 18 (3.1) | |
Additional antibiotic doses | |||
Yes (%) | 1 (25.0) | 20 (3.5) | P = 0.137; Fisher’s test |
Not (%) | 3 (75.0) | 559 (96.5) | |
Diagnosis | |||
Coxartrosis (%) | 3 (75.0) | 370 (97.6) | P = 1.00; Fisher’s test |
Dysplasia (%) | 1 (25.0) | 9 (2.4) | |
Bearings | |||
Cer-cer (%) | 4 (100.0) | 522 (90.2) | P = 0.001; χ2 test |
Cer-pol (%) | - | 8 (1.4) | |
Met-pol (%) | - | 49 (8.5) | |
Steroid | |||
Yes (%) | 1 (25.0) | 14 (2.4) | P = 0.1; Fisher’s test |
Not (%) | 3 (75.0) | 562 (97.6) | |
Immunosuppressants | |||
Yes (%) | - | 13 (2.3) | P = 0.1; Fisher’s test |
Not (%) | 4 (100.0) | 564 (97.7) | |
Antiaggregant drugs | |||
Yes (%) | 1 (25.0) | 116 (20.1) | P = 1.00; Fisher’s test |
Not (%) | 3 (75.0) | 460 (79.9) | |
Local surgery before the operation | |||
Yes (%) | - | 66 (11.5) | P = 1.00; Fisher’s test |
Not (%) | 4 (100.0) | 507 (88.5) | |
COPD | |||
Yes (%) | - | 78 (13.5) | P = 1.00; Fisher’s test |
Not (%) | 4 (100.0) | 500 (86.5) | |
Chronic renal insufficiency | |||
Yes (%) | 1 (25.0) | 20 (3.5) | P = 0.137; Fisher’s test |
Not (%) | 3 (75.0) | 558 (96.5) | |
Preexisting heart ischemic conditions | |||
Yes (%) | 1 (25.0) | 51 (8.8) | P = 0.313; Fisher’s test |
Not (%) | 3 (75.0) | 527 (91.2) | |
Diabetes | |||
Yes (%) | - | 44 (7.6) | P = 1.00; Fisher’s test |
Not (%) | 4 (100.0) | 533 (92.4) | |
Rheumatological conditions | |||
Yes (%) | - | 12 (2.1) | P = 1.00; Fisher’s test |
Not (%) | 4 (100.0) | 565 (97.9) | |
Previously local septic conditions | |||
Yes (%) | - | 6 (1.0) | P = 1.00; Fisher’s test |
Not (%) | 4 (100.0) | 571 (99.1) | |
Blood transfusion | |||
Yes (%) | 1 (25.0) | 98 (16.9) | P = 1.00; Fisher’s test |
Not (%) | 3 (75.0) | 468 (80.8) | |
Prosthesis fixation | |||
Uncemented (%) | 4 (100.0) | 570 (98.4) | P = 1.00; Fisher’s test |
Cemented stem and uncemented cup (%) | - | 9 (1.6) | |
Time of intervention | |||
(07-12) (%) | 4 (100.0) | 442 (76.3) | P = 0.578; Fisher’s test |
(12-19) (%) | 0 | 137 (23.7) |
Infection (yes) | Infection (not) | |||||||
Pre | T1 | T2 | Last | Pre | T1 | T2 | Last | |
Hemoglobin | 14.6 | 11.0 | 10.6 | 10.7 | 13.9 | 11.1 | 10.0 | 10.1 |
White blood cells | 8177.5 | 7360.0 | 7257.5 | 7040.0 | 7192.5 | 9821.5 | 8997.6 | 7764.4 |
- Citation: Tella GF, Donadono C, Castagnini F, Bordini B, Cosentino M, Di Liddo M, Traina F. Preoperative and postoperative risk factors for periprosthetic joint infection in primary total hip arthroplasty: A 1-year experience . World J Orthop 2022; 13(10): 903-910
- URL: https://www.wjgnet.com/2218-5836/full/v13/i10/903.htm
- DOI: https://dx.doi.org/10.5312/wjo.v13.i10.903